[1]ZHU DQ,WU H,GONG JP.Gene polymorphisms in non-alcoholic fatty liver disease:a review of research progress[J].J Clin Hepatol,2015,31(7):1163-1167.(in Chinese)朱端权,吴皓,龚建平.非酒精性脂肪性肝病基因多态性的研究进展[J].临床肝胆病杂志,2015,31(7):1163-1167.
|
[2]RAU M,WEISS J,GEIER A.Non-alcoholic fatty liver disease(NAFLD)[J].Dtsch Med Wochenschr,2015,140(14):1051-1055.
|
[3]HOU YX,WANG XB,YANG YY,et al.Action of mechanlsm of traditional Chinese medicine in prevention and treatment of non-alcoholic fatty liver disease[J].J Clin Hepatol,2016,32(4):785-789.(in Chinese)侯艺鑫,王宪波,杨玉英,等.中医药防治非酒精性脂肪性肝病的作用机制[J].临床肝胆病杂志,2016,32(4):785-789.
|
[4]MA JM,WANG JQ.Treatment of non-alcoholic fatty liver disease from deficiency[J].J Changchun Univ Tradit Chin Med,2014,30(10):850-852.(in Chinese)马菁蔓,王景泉.从虚论治非酒精性脂肪肝[J].长春中医药大学学报,2014,30(10):850-852.
|
[5]YAN J,XIE W,OU WN,et al.Epidemiological survey and risk factor analysis of fatty liver disease of adult residents,Beijing,China[J].J Gastroenterol Hepatol,2013,28(10):1654-1659.
|
[6]FARGION S,MATTIOLI M,FRACANZANI AL,et al.Hyperferritinemia,iron overload,and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis[J].Am J Gastroenterol,2001,96(8):2448-2455.
|
[7]BUGIANESI E,MANZINI P,D'ANTICO S,et al.Relative contribution of iron burden,HFE mutations,and insulin resistance to fibrosis in nonalcoholic fatty liver[J].Hepatology,2004,39(1):179-187.
|
[8]NELSON JE,WILSON L,BRUNT EM,et al.Relationship between pattern of hepatic iron deposition and histologic severity in nonalcoholic fatty liver disease[J].Hepatology,2011,53(2):448-457.
|
[9]SUMIDA Y,YOSHIKAWA T,OKANOUE T.Role of hepatic iron in non-alcoholic steatohepatitis[J].Hepatology Research,2009,39(3):213-222.
|
[10]Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association.Guidelines for diagnosis and treatment of nonalcoholic fatty liver diseases[J].J Clin Hepatol,2010,26(2):120-124.(in Chinese)中华医学会肝病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].临床肝胆病杂志,2010,26(2):120-124.
|
[11]DING R,JIA JD.Progress in evaluation and treatment of hepatic iron oveload[J].J Clin Hepatol,2014,30(9):961-964.(in Chinese)丁蕊,贾继东.肝脏铁过载的评估及治疗新进展[J].临床肝胆病杂志,2014,30(9):961-964.
|
[12]VALENTI L,DONGIOVANNI P,FARGION S.Diagnostic and therapeutic implications of the association between ferritin level and severity of non-alcoholicfatty liver disease[J].World J Gastroenterol,2012,18(29):3782-3786.
|
[13]TSUCHIYA H,EBATA Y,SAKABE T,et al.High-fat,high-fructose diet induces hepatic iron overload via a hepcidin-independent mechanism prior to the onset of liver steatosis and insulin resistance in mice[J].Metabolism,2012,62(1):62-69.
|
[14]KOWDLEY KV,BELT P,WILSON LA,et al.Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease[J].Hepatology,2012,55(1):77-85.
|
[15]MALIKEN BD,NELSON JE,KLINTWORTH HM,et al.Hepatic reticuloendothelial system cell iron deposition is associated with increased apoptosis in nonalcoholic fatty liver disease[J].Hepatology,2013,57(5):1806-1813.
|
[16]SORRENTINO P,D’ANGELO S,FERBO U,et al.Liver iron excess in patients with hepatocellular carcinoma developed on nonalcoholic steato-hepatitis[J].J Hepatol,2009,50(2):351-357.
|
[17]CHEN X,LONG J,DU HY,et al.Clinical analysis of iron metabolism in patients with nonalcoholic fatty liver disease[J].Lab Med Clin,2015,12(23):3484-3486.(in Chinese)陈学,龙静,杜梅英,等.非酒精性脂肪肝患者体内铁代谢水平临床分析[J].检验医学与临床,2015,12(23):3484-3486.
|
[18]MOYER TP,HIGHSMITH WE,SMYRK T,et al.Hereditary hemochromatosis:laboratory evaluation[J].Clin Chim Acta,2011,412(17-18):1485-1492.
|
[19]BARTON JC,BARTON JC,ACTON RT,et al.Increased risk of death from iron overload among 422 treated probands with HFE hemochromatosis and serum levels of ferritin greater than 1000μg/L at diagnosis[J].Clin Gastroenterol Hepatol,2012,10(4):412-416.
|
[20]LI GM,FAN JG.Research progress in role of iron over loading in nonalcoholic fatty liver disease[J].J Clin hepatol,2013,29(12):897-900.(in Chinese)李光明,范建高.铁超载在非酒精性脂肪性肝病中的作用[J].临床肝胆病杂志,2013,29(12):897-900.
|
[21]NELSON JE,BRUNT EM,KOWDLEY KV.Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations[J].Hepatology,2012,56(6):1730-1740.
|